chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

HC Wainwright & Co. Initiates Coverage On Cabaletta Bio with Buy Rating, Announces Price Target of $20

Benzinga | Oct 13, 2020 6:59 AM EDT
HC Wainwright & Co. Initiates Coverage On Cabaletta Bio with Buy Rating, Announces Price Target of $20

HC Wainwright & Co. initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Buy rating and announces Price Target of $20.